This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Dale Lewis - Innovator in PCSK9 Immunoassay Technology
Introduction
Dale Lewis is an accomplished inventor based in Washington Crossing, PA (US). He has made significant contributions to the field of immunoassays, particularly in the measurement of circulating PCSK9 levels. His innovative work has implications for understanding cholesterol metabolism and cardiovascular health.
Latest Patents
Dale Lewis holds a patent for a method related to PCSK9 immunoassays. The patent, titled "Methods of using PCSK9 antagonists," outlines techniques for measuring circulating PCSK9 levels in biological samples through an immunoassay. This method employs a solid phase immunoassay, specifically utilizing a dissociation-enhanced lanthanide fluorescence immunoassay with an E07 capture antibody and a G08 or H23 detecting antibody. This patent represents a significant advancement in the field of biochemistry and diagnostics, with 1 patent to his name.
Career Highlights
Dale Lewis is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck has allowed him to further develop his expertise in immunoassay technologies and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Dale has collaborated with notable colleagues, including Yan Ni and Sharon Lobo. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.
Conclusion
Dale Lewis is a prominent inventor whose work in PCSK9 immunoassays has the potential to impact the medical field significantly. His contributions to the understanding of cholesterol metabolism are invaluable, and his ongoing work at Merck Sharp & Dohme Corp. continues to drive innovation in healthcare.